About

Harsher Singh was appointed CEO of Jubilant Radiopharma in April 2024. With a proven track record in the biopharmaceutical industry, Harsher brings valuable expertise to the radiopharmaceutical division. Prior to joining the Jubilant team, Harsher was Senior Vice President at Amneal Biosciences where he led the Biosimilar, Biologic and Injectable business lines and served as Amneal's strategic leader for AvKare Distribution Business. Prior to Amneal, he worked for American Regent, Inc. and McKinsey & Company. Harsher holds an MBA from Northwestern University – Kellogg School of Management, and a BSc in Economics from the London School of Economics and Political Science.

Appointed Sr. Vice President & CSO for the Radiopharmaceuticals Division in Jan 2023, bringing over 20 years of leadership experience in a variety of R&D and regulatory positions in large multinational companies.

Previously, Indranil was CSO for Jubilant Pharma for 3.5 years. He was also CSO of Vertice pharma. He led a large R&D team & sites at Impax Lab, Sandoz,

Appointed Vice President and Chief Medical Officer the Radiopharmaceuticals Division in April 2022, bringing over 30 years of experience in medicine, cardiology, research, imaging and innovation in academic and pharmaceutical medicine to global healthcare.

Previously, Melda was Global Medical and Regulatory Affairs Executive Senior Director at Bracco Diagnostics and Research Professor at Saint Louis University Hospital Cardiology. She served as a key opinion leader in healthcare globally.

Brent Durham possesses nearly three decades of experience in sales and leadership roles in the healthcare and safety industries, most recently as Chief Commercial Officer (Global) for Jubilant Radiopharmaceuticals. Over the years, Brent has served in various leadership and sales roles with Canon, Honeywell, GE Healthcare, Philips, and Merck. Brent also served active duty as a Officer in the United States Army.

In his current role, Brent leads Sales, Business Analytics, Clinical Applications, and Customer Services, for all of Jubilant Radiopharmaceuticals globally. Brent plays a vital role as the champion for all of Jubilant Radiopharma's global product and customer service activities. Brent is responsible for driving global sales efforts, managing distribution partnerships, business forecasting and modeling, and delivering customer service on 5 continents.